News

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap
Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...
Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc.
Hoodline1d
Indian Nationals Sentenced to 30 Months for Smuggling Counterfeit Cancer Drugs into U.S.
Two Indian nationals were sentenced to 30 months in prison for smuggling counterfeit cancer drugs into the US.
Major deals involving U.S. drugmakers and biotechs over the past decade
Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond ...
Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps
Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...
Brothers sentenced to prison for smuggling fake and contaminated drugs
Two brothers from India were sentenced to 30 months in prison after they were found guilty of trying to sell counterfeit, ...
Explore more
Trump's Drug Tariffs: Where Does the U.S. Import Pharmaceuticals From?
President Trump has threatened to slap a 200% tariff on foreign-made pharmaceuticals. That would roil the $200 billion-plus ...
The Globe and Mail3h
Merck Faces Multiple Challenges: Will It Steer Through Successfully?
Merck MRK is expected to face several hurdles over the next few years that could affect its long-term growth trajectory, starting with the anticipated loss of exclusivity of its blockbuster PD-L1 ...